These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36163408)

  • 1. Optimized Rhombic Experimental Dynamic Checkerboard Designs to Elucidate Pharmacodynamic Drug Interactions of Antibiotics.
    Kroemer N; Aubry R; Couet W; Grégoire N; Wicha SG
    Pharm Res; 2022 Dec; 39(12):3267-3277. PubMed ID: 36163408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons of Analysis Methods for Assessment of Pharmacodynamic Interactions Including Design Recommendations.
    Chen C; Wicha SG; Nordgren R; Simonsson USH
    AAPS J; 2018 Jun; 20(4):77. PubMed ID: 29931471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Do different interpretative methods used for evaluation of checkerboard synergy test affect the results?].
    Ozseven AG; Sesli Çetin E; Ozseven L
    Mikrobiyol Bul; 2012 Jul; 46(3):410-20. PubMed ID: 22951653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment and modelling of antibacterial combination regimens.
    Rao GG; Li J; Garonzik SM; Nation RL; Forrest A
    Clin Microbiol Infect; 2018 Jul; 24(7):689-696. PubMed ID: 29269090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinations.
    Clewe O; Wicha SG; de Vogel CP; de Steenwinkel JEM; Simonsson USH
    J Antimicrob Chemother; 2018 Feb; 73(2):437-447. PubMed ID: 29136155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method.
    Brennan-Krohn T; Kirby JE
    J Vis Exp; 2019 Apr; (146):. PubMed ID: 31058886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic modelling of β-lactam/β-lactamase inhibitor checkerboard data: illustration with aztreonam-avibactam.
    Chauzy A; Buyck J; de Jonge BLM; Marchand S; Grégoire N; Couet W
    Clin Microbiol Infect; 2019 Apr; 25(4):515.e1-515.e4. PubMed ID: 30543853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing in vitro combinations of antifungal drugs against yeasts and filamentous fungi: comparison of different drug interaction models.
    Meletiadis J; Verweij PE; TeDorsthorst DT; Meis JF; Mouton JW
    Med Mycol; 2005 Mar; 43(2):133-52. PubMed ID: 15832557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting in vitro antibacterial efficacy across experimental designs with a semimechanistic pharmacokinetic-pharmacodynamic model.
    Nielsen EI; Cars O; Friberg LE
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1571-9. PubMed ID: 21282424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semi-mechanistic pharmacokinetic-pharmacodynamic modelling of antibiotic drug combinations.
    Brill MJE; Kristoffersson AN; Zhao C; Nielsen EI; Friberg LE
    Clin Microbiol Infect; 2018 Jul; 24(7):697-706. PubMed ID: 29229429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental designs for detecting synergy and antagonism between two drugs in a pre-clinical study.
    Sperrin M; Thygesen H; Su TL; Harbron C; Whitehead A
    Pharm Stat; 2015; 14(3):216-25. PubMed ID: 25810342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A method for testing for synergy with any number of agents.
    Berenbaum MC
    J Infect Dis; 1978 Feb; 137(2):122-30. PubMed ID: 627734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?
    Zharkova MS; Orlov DS; Golubeva OY; Chakchir OB; Eliseev IE; Grinchuk TM; Shamova OV
    Front Cell Infect Microbiol; 2019; 9():128. PubMed ID: 31114762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of in vitro synergy between vertilmicin and ceftazidime against Pseudomonas aeruginosa using a semi-mechanistic pharmacokinetic/pharmacodynamic model.
    Zhuang L; Sy SK; Xia H; Singh RP; Mulder MB; Liu C; Derendorf H
    Int J Antimicrob Agents; 2015 Feb; 45(2):151-60. PubMed ID: 25465523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of ED-optimality to screening experiments for analgesic compounds in an experimental model of neuropathic pain.
    Taneja A; Nyberg J; de Lange EC; Danhof M; Della Pasqua O
    J Pharmacokinet Pharmacodyn; 2012 Dec; 39(6):673-81. PubMed ID: 23197247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An R-shiny application to calculate optimal designs for single substance and interaction trials in dose response experiments.
    Holland-Letz T; Kopp-Schneider A
    Toxicol Lett; 2021 Feb; 337():18-27. PubMed ID: 33232777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New concept and a theoretical consideration of the mechanism-based pharmacokinetics/ pharmacodynamics (PK/PD) modeling for antimicrobial agents.
    Sato N; Suzuki H; Hayashi H; Shibasaki S; Sugano T; Maebashi K; Kurosawa T; Shiomi M; Ogata H
    Jpn J Antibiot; 2008 Oct; 61(5):314-38. PubMed ID: 19260351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergy of β-Lactams with Vancomycin against Methicillin-Resistant Staphylococcus aureus: Correlation of Disk Diffusion and Checkerboard Methods.
    Sy CL; Huang TS; Chen CS; Chen YS; Tsai HC; Wann SR; Wu KS; Chen JK; Lee SS; Liu YC
    J Clin Microbiol; 2016 Mar; 54(3):565-8. PubMed ID: 26677253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic and response surface analysis of linezolid or vancomycin combined with meropenem against Staphylococcus aureus.
    Wicha SG; Kees MG; Kuss J; Kloft C
    Pharm Res; 2015 Jul; 32(7):2410-8. PubMed ID: 25630818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.